She has engaged in a series of basic research and hypertension epidemiology practice exploration more than ten years, and have a complete research system. She conducted in-depth research on the environment, nutrition, genomics and drug of high incidence of hypertension and stroke in China. She first proposed the theory that HHcy inhibits angiogenesis and aggravates coronary heart disease; HHcy and MTHFR CBS gene polymorphism - stroke precision medical exploration theory. She has won the outstanding young scientific and technological talents of Jiangxi Province, the special clinical Award for young doctors of American Chinese Heart Association, the second prize of Jiangxi science and Technology Progress Award (ranked fourth), and the excellent doctoral thesis of Jiangxi Province. 87 papers have been published (15 of the first author / corresponding author).